Michael Harty (Clare, Independent) | Oireachtas source

In our first session, we are meeting the Minister for Health, Deputy Harris, and his officials, and Ms Laura Magahy, the recently appointed executive director of Sláintecare regarding the Sláintecare strategy. On behalf of the committee I welcome the Minister and Ms Magahy to the committee.

I draw attention to the fact that by virtue of section 17(2)(l) of the Defamation Act 2009, witnesses are protected by absolute privilege in respect of their evidence to this committee. However, if they are directed by the committee to cease giving evidence on a particular matter and continue to so do, they are entitled thereafter only to qualified privilege in respect of their evidence. They are directed that only evidence connected with the subject matter of these proceedings is to be given and asked to respect the parliamentary practice to the effect that, where possible, they should not criticise nor make charges against any person, persons or entity by name or in such a way as to make him, her or it identifiable. I also advise them that any opening statements given to the committee may be published on the committee's website after the meeting.

Members are reminded of the long-standing parliamentary practice to the effect that they should not comment on, criticise or make charges against a person outside the Houses or an official either by name or in such a way as to make him or her identifiable.

I call the Minister to make his opening contribution.